The Venture Codex Logo

The Venture Codex

AfterWork Ventures

Sydney, New South Wales, 2016, Australia

Overview

AfterWork Ventures is a growing entrant in its early stages. Their investment process is infused with a deep appreciation for the founders' time, intelligence, and courage. Founders are commonly exposed to torturous, time-consuming due diligence processes, only to be unceremoniously rejected despite their efforts. They committed to showing up for founders and created a transparent process that adds value at every step.

Total investments
18
Lead investments
1
Investments · 12mo
2
Active investors
6
Visit website

Investment portfolio

  • Enrola

    Participated · Seed · Aug 2026

    Enrola develops AI-powered sales agents designed to engage and convert customers in high-consideration B2C sales. Founded in 2023 and led by co-founders Jo Thomas (CEO) and Yvette Quinby (CTO), the company pivoted in 2025 from an education comparison platform to specialized sales technology. Its platform aims to address lead leakage for businesses selling high-value consumer services. Enrola raised $2.1 million in a Seed round to scale its agents, expand into additional industries, and adapt its technology to changing consumer purchase behaviors. Articles do not disclose revenue, user metrics, or prior round amounts.

  • Lyka Pet Food

    Participated · Series C · Mar 2026

    Founded in 2018 by veterinarian Dr. Matthew Muir and co-founder Anna Podolsky, Sydney-based Lyka Pet Food produces human-grade, fresh dog meals that are tailored to each animal’s weight, breed, age and activity level. Menu options range from grass-fed beef and lamb to free-range chicken, goat, kangaroo and turkey, combined with vegetables and superfoods such as quinoa, spinach, kale and chia seeds. Sold exclusively online on a weekly subscription basis, the service costs about A$28–50 per week for a small dog. The company claims roughly A$200 million in annual recurring revenue and has invested A$16 million in a dedicated production facility in Dandenong, Victoria, alongside additional kitchens in Sydney. Lyka markets aggressively, gaining notoriety for a viral (and Netflix-banned) ad highlighting the benefits of fresh food on dog digestion. With significant venture backing, the startup continues to scale manufacturing capacity and broaden its direct-to-consumer reach across Australia.

  • Switchboard

    Participated · Equity · Jun 2024

    Switchboard provides a cloud integration platform designed to make IT system integration accessible to small and mid-sized supply chain players. The product automates communication among customers, suppliers, logistics providers and other trading partners to improve operational efficiency. It focuses on truckload optimization, reducing costs per consignment and staffing, and delivering more precise demand forecasts. Founder Hugh Dixson, drawing on experience at Ofload, Uber and Boston Consulting Group, launched the company in August 2022 to address lagging digital adoption in logistics. The company reports rapid traction in manufacturing, retail and food & beverage sectors and plans to expand its customer base and global presence. Financially, Switchboard recently raised A$1.5M to support product development and growth.

  • Samphire Neuroscience

    Participated · Seed · Feb 2024

    Samphire Neuroscience is developing Nettle, a battery-operated headband that delivers non-invasive transcranial direct current stimulation (tDCS) targeting the motor cortex and prefrontal cortex to reduce menstrual pain and mood symptoms. The device is designed to be worn for five days before a period and pairs with an app that includes period tracking, treatment reminders and research participation. Samphire reports a clinical trial of around 50 participants used in its CE application that showed an average 52% decrease in pain with active use and some lingering benefit the month after treatment. Nettle is not intended as a treatment for diagnosed endometriosis and common side effects reported are mild (itching/tingling or transient migraines). The company is pursuing a Class 2A CE mark, plans an initial production run of 1,000 devices, will sell direct-to-consumer and via retailer and hospital partners, and hopes for insurer reimbursement. Samphire intends to expand its product line into other female-focused therapeutics (insomnia and perimenopause) and estimates a U.S. launch in 1.5–2 years, seeking FDA breakthrough designation for U.S. trials.

  • Indemn

    Participated · Seed · Jan 2024

    Indemn is an insurtech SaaS provider delivering an AI-powered conversational insurance platform built around Large Language Models. Its platform includes AI agents that support all aspects of digital insurance, from quoting to purchase, and can route customers to human agents supported by an AI-powered Copilot. The product is designed to deliver insurance agents directly to users across distribution channels, aiming to drive growth and reduce operational costs for carriers. Led by CEO Kyle Geoghan, the company positions its technology to transform the insurance acquisition experience through natural conversation. Indemn intends to use the new funding to accelerate growth and further develop its conversational delivery of insurance products. The company raised $1.9M in a pre-seed round to support these plans.

Team